A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than ...

The latest version of a bionic pancreas device has been successfully tested in two five-day clinical trials -- one in adults, the other in adolescents -- that imposed minimal restrictions on patient ...

A fully automated bionic pancreas improved HbA1c in children and adults with type 1 diabetes, a multicenter randomized trial showed. Use of this bionic pancreas system led to a drop in HbA1c from 7.9% ...

A bionic pancreas—a wearable, pocket-sized, automated insulin delivery device—that was first developed in a Boston University lab has been cleared by the U.S. Food and Drug Administration (FDA). The ...

The bionic pancreas uses algorithms to continually adjust insulin doses based on the user’s needs, requiring less user input compared with other existing artificial pancreas technologies. A bionic ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. NEW ORLEANS — Adults and children with type 1 diabetes ...

Please provide your email address to receive an email when new articles are posted on . The iLet bionic pancreas system conferred an average glucose of less than 183 mg/dL in 97% of adults with type 1 ...

Among the adults, the mean plasma glucose level over the 5-day bionic-pancreas period was 138 mg per deciliter (7.7 mmol per liter), and the mean percentage of time with a low glucose level (<70 mg ...